Skip to main content
. Author manuscript; available in PMC: 2019 Oct 1.
Published in final edited form as: Mol Immunol. 2018 Jun 27;102:3–13. doi: 10.1016/j.molimm.2018.06.264

Figure 3. C5aR1 Antagonist Suppresses AD-like Pathology in Mouse Models.

Figure 3

PMX205 substantially reduces thioflavine plaques (A,B), microglial CD45 (C,D) and hyperphosphorylated tau (AT100, E,F) (45-70%) in Tg2576 (A-D) and 3×Tg (E,F). Scale bar is 100um (A,B) or 50um (C-F). From Fonseca et al. (2009) J. Immunology 183:1375–1383. (currently #68)